The total return over the past 12 months is -5.53% vs. +20.58% for the S&P 500. So far it's up -2.31% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (10.52%) | (5.66%) | (2.86%) | +1.46% | +1.50% | +0.07% |
| Total Return CAGR | (5.53%) | (1.21%) | +1.38% | +5.69% | +5.63% | +4.23% |
| Revenue CAGR | +18.92% | +5.38% | +4.96% | +4.53% | +1.41% | +2.29% |
| Net Income CAGR | (55.39%) | (20.29%) | (7.66%) | (0.22%) | (1.71%) | +0.29% |
| EPS CAGR | (87.41%) | +3.27% | (8.92%) | +7.75% | +1.95% | +6.87% |
| Free Cash Flow CAGR | N/A | +9.75% | +12.83% | +5.96% | +0.56% | +3.31% |
| Operating Cash Flow CAGR | N/A | +8.16% | +9.39% | +3.93% | +0.58% | +3.21% |
| Dividends CAGR | +10.19% | +8.32% | +4.88% | +4.03% | +1.91% | +5.00% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Sanofi (SNY)
| Year | Start price | End price | SNY Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $48.46 | $44.84 | (2.31%) | +13.68% | (15.99%) |
| 2025 | $48.23 | $48.46 | +4.90% | +17.72% | (12.82%) |
| 2024 | $49.73 | $48.23 | +1.04% | +24.89% | (23.85%) |
| 2023 | $48.43 | $49.73 | +6.56% | +26.19% | (19.63%) |
| 2022 | $50.10 | $48.43 | +0.42% | (18.17%) | +18.59% |
| 2021 | $48.59 | $50.10 | +6.97% | +28.74% | (21.77%) |
| 2020 | $50.20 | $48.59 | +0.42% | +18.37% | (17.95%) |
| 2019 | $43.41 | $50.20 | +20.53% | +31.22% | (10.69%) |
| 2018 | $43.00 | $43.41 | +5.95% | (4.56%) | +10.51% |
| 2017 | $40.44 | $43.00 | +9.80% | +21.70% | (11.90%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
